While the condition, called lymphoedema, affects about 300,000 Britons - the most common cause is cancer treatment - few are able to access the £15,000 procedure on the health service.
Patients battling cancer are urging the Federal Government to provide free treatment, similar to the support available for those with HIV/AIDS. The patients made their appeal at the Ahmadu Bello University Teaching Hospital, Shika.…
Since the first time she treated a child with neuroblastoma, Giselle Saulnier Sholler wanted to do the impossible for her patients. Neuroblastoma is the most common extracranial solid tumor in children with roughly 700 new diagnoses every…
Researchers from King's College have led research that has resulted in the publication of first-of-their-kind guidelines that seek to standardize how clinicians measure the immune response of patients who have myelodysplastic syndromes …
(MedPage Today) -- A surgical team at Mayo Clinic Arizona in Phoenix performed the first total larynx transplant in an active cancer patient in the U.S. He had lost the ability to speak, swallow, and breathe as a result of treatment for a…
At the 2024 ESPY Awards on Thursday, Dawn Staley received the Jimmy V Award for Perseverance. This award honors her advocacy for equality in women’s sports and her leadership in the fight against cancer. For the event, the coach of the…
Immunotherapy can be a highly effective treatment for non-small cell lung cancer (NSCLC), but some patients are resistant to the therapy or develop intolerable side effects.
Immutep announces results from Cohort B of the TACTI-003 Phase 2b trial. The combination of eftilagimod alfa and Merck's Keytruda shows a 35.5% ORR and 58.1% DCR in PD-L1 negative head and neck cancer patients, with no new safety concerns.
The artificial intelligence (AI) model GPT-4, known from its application in ChatGPT, shows impressive capabilities in biomedical research and can be used in many ways for simulations. A simulator developed at MedUni Vienna and based on GPT…
A recent European Urology Oncology study assessed the mortality risks, based on the Gleason score and clinical parameters, in patients with prostate cancer.